Total Funding
2
21
Total FundingVenture - Series Unknown raised
Growth Score
-12 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
721545
nanoTherics offers IP-protected products that support the field of magnetic nanoparticle research and applications.
- Jon Dobson: Founder
- Carlton Jones: Chief Executive Officer
About the Company
nanoTherics gene transfection studies have shown a significant performance enhancement over the best non-viral techniques currently on the market, demonstrating high levels of transfection whilst, importantly, maintaining the viability of the transfected cells. These two key attributes afford a significant competitive advantage over currently
available systems.
nanoTherics’s mission is to position its novel gene transfection technology as the new “gold standard“ for transfection, underpinning the research and development of current and future gene therapy programmes.
